American Journal of Kidney Diseases
Volume 50, Issue 1 , Pages 59-68 , July 2007

Changes in Serum 25-Hydroxyvitamin D and Plasma Intact PTH Levels Following Treatment With Ergocalciferol in Patients With CKD

  • Ziyad Al-Aly, MD

      Affiliations

    • Division of Nephrology, Saint Louis Veterans Affairs Medical Center, St Louis, MO
    • Division of Nephrology, Saint Louis University, St Louis, MO
    • Corresponding Author InformationAddress correspondence to Ziyad Al-Aly, MD, Saint Louis Veterans Administration Medical Center, Division of Nephrology 111B-JC, 915 North Grand Boulevard, St Louis, MO 63106.
    • ,
  • Rizwan A. Qazi, MD

      Affiliations

    • Division of Nephrology, Saint Louis University, St Louis, MO
    • ,
  • Esther A. González, MD

      Affiliations

    • Division of Nephrology, Saint Louis University, St Louis, MO
    • ,
  • Angelique Zeringue, MS

      Affiliations

    • Department of Research and Education, Saint Louis Veterans Affairs Medical Center, St Louis, MO.
    • ,
  • Kevin J. Martin, MBBCh

      Affiliations

    • Division of Nephrology, Saint Louis University, St Louis, MO

Received 11 December 2006 ,Accepted 9 April 2007.

References 

  1. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis. 2003;41:1–12
  2. US Renal Data System. The United States Renal Data Report 2004. Am J Kidney Dis. 2003;42:1–230
  3. Gonzalez EA, Sachdeva A, Oliver DA, Martin KJ. Vitamin D insufficiency and deficiency in chronic kidney disease (A single center observational study). Am J Nephrol. 2004;24:503–510
  4. LaClair RE, Hellman RN, Karp SL, et al. Prevalence of calcidiol deficiency in CKD: A cross-sectional study across latitudes in the United States. Am J Kidney Dis. 2005;45:1026–1033
  5. Thomas MK, Lloyd-Jones DM, Thadhani RI, et al. Hypovitaminosis D in medical inpatients. [see comments] N Engl J Med. 1998;338:777–783
  6. National Kideny Foundation. K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease. Am J Kidney Dis. 2003;42(suppl 3):S1–S201
  7. Halloran BP, Schaefer P, Lifschitz M, Levens M, Goldsmith RS. Plasma vitamin D metabolite concentrations in chronic renal failure: Effect of oral administration of 25-hydroxyvitamin D3. J Clin Endocrinol Metab. 1984;59:1063–1069
  8. Lin J, Knight EL, Hogan ML, Singh AK. A comparison of prediction equations for estimating glomerular filtration rate in adults without kidney disease. J Am Soc Nephrol. 2003;14:2573–2580
  9. Levey ASGT, Kusek JW, Beck GJ MDRD Study Group. A simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol. 2000;11:155A;(abstr)
  10. Block GA, Martin KJ, de Francisco AL, et al. Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis. N Engl J Med. 2004;350:1516–1525
  11. Martin KJ, Gonzalez EA, Gellens M, Hamm LL, Abboud H, Lindberg J. 19-Nor-1-alpha-25-dihydroxyvitamin D2 (paricalcitol) safely and effectively reduces the levels of intact parathyroid hormone in patients on hemodialysis. J Am Soc Nephrol. 1998;9:1427–1432
  12. Cannata-Andia JB, Gomez Alonso C. Vitamin D deficiency: A neglected aspect of disturbed calcium metabolism in renal failure. Nephrol Dial Transplant. 2002;17:1875–1878
  13. Fournier A, Fardellone P, Achard JM, et al. Importance of vitamin D repletion in uraemia. Nephrol Dial Transplant. 1999;14:819–823
  14. Masuda S, Byford V, Arabian A, et al. Altered pharmacokinetics of 1alpha,25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3 in the blood and tissues of the 25-hydroxyvitamin D-24-hydroxylase (Cyp24a1) null mouse. Endocrinology. 2005;146:825–834
  15. Jones G, Byford V, West S, et al. Hepatic activation and inactivation of clinically-relevant vitamin D analogs and prodrugs. Anticancer Res. 2006;26:2589–2595
  16. Boudville NC, Hodsman AB. Renal function and 25-hydroxyvitamin D concentrations predict parathyroid hormone levels in renal transplant patients. Nephrol Dial Transplant. 2006;21:2621–2624
  17. Nykjaer A, Dragun D, Walther D, et al. An endocytic pathway essential for renal uptake and activation of the steroid 25-(OH) vitamin D3. Cell. 1999;96:507–515
  18. Gallieni M, Kamimura S, Ahmed A, et al. Kinetics of monocyte 1 alpha-hydroxylase in renal failure. Am J Physiol. 1995;268:F746–F753
  19. Dusso A, Finch J, Delmez J, et al. Extrarenal production of calcitriol. Kidney Int Suppl. 1990;29:S36–S40
  20. Ritter CS, Armbrecht HJ, Slatopolsky E, Brown AJ. 25-Hydroxyvitamin D(3) suppresses PTH synthesis and secretion by bovine parathyroid cells. Kidney Int. 2006;70:654–659
  21. Reichel H, Koeffler HP, Norman AW. The role of the vitamin D endocrine system in health and disease. N Engl J Med. 1989;320:980–991
  22. Levin A, Li YC. Vitamin D and its analogues: Do they protect against cardiovascular disease in patients with kidney disease?. Kidney Int. 2005;68:1973–1981
  23. Hayes CE, Nashold FE, Spach KM, Pedersen LB. The immunological functions of the vitamin D endocrine system. Cell Mol Biol (Noisy-le-grand). 2003;49:277–300
  24. Liu PT, Stenger S, Li H, et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science. 2006;311:1770–1773
  25. London GM, Verbeke FH, Pannier B, Boutouyrie P, Marchais SJ, Mëtivier F. Mineral metabolism and arterial functions in end-stage renal disease: Potential role of 25-hydroxyvitamin D deficiency. J Am Soc Nephrol. 2006;18:613–620
  26. Targher G, Bertolini L, Padovani R, et al. Serum 25-hydroxyvitamin D3 concentrations and carotid artery intima-media thickness among type 2 diabetic patients. Clin Endocrinol (Oxf). 2006;65:593–597
  27. Dusso AS, Brown AJ, Slatopolsky E. Vitamin D. Am J Physiol Renal Physiol. 2005;289:F8–F28
  28. Spina CS, Tangpricha V, Uskokovic M, Adorinic L, Maehr H, Holick MF. Vitamin D and cancer. Anticancer Res. 2006;26:2515–2524
  29. Holick MF. Vitamin D: Important for prevention of osteoporosis, cardiovascular heart disease, type 1 diabetes, autoimmune diseases, and some cancers. South Med J. 2005;98:1024–1027
  30. Grant WB, Garland CF. The association of solar ultraviolet B (UVB) with reducing risk of cancer: Multifactorial ecologic analysis of geographic variation in age-adjusted cancer mortality rates. Anticancer Res. 2006;26:2687–2699
  31. Hypponen E, Laara E, Reunanen A, Jarvelin MR, Virtanen SM. Intake of vitamin D and risk of type 1 diabetes: A birth-cohort study. Lancet. 2001;358:1500–1503
  32. Merlino LA, Curtis J, Mikuls TR, Cerhan JR, Criswell LA, Saag KG. Vitamin D intake is inversely associated with rheumatoid arthritis: Results from the Iowa Women’s Health Study. Arthritis Rheum. 2004;50:72–77
  33. Bouillon R, Eelen G, Verlinden L, Mathieu C, Carmeliet G, Verstuyf A. Vitamin D and cancer. J Steroid Biochem Mol Biol. 2006;102:156–162
  34. Vieth R. The role of vitamin D in the prevention of osteoporosis. Ann Med. 2005;37:278–285
  35. Bischoff-Ferrari HA, Willett WC, Wong JB, Giovannucci E, Dietrich T, Dawson-Hughes B. Fracture prevention with vitamin D supplementation: A meta-analysis of randomized controlled trials. JAMA. 2005;293:2257–2264
  36. Heaney RP. The vitamin D requirement in health and disease. J Steroid Biochem Mol Biol. 2005;97:13–19
  37. Andress DL. Vitamin D in chronic kidney disease: A systemic role for selective vitamin D receptor activation. Kidney Int. 2006;69:33–43

 Trial registration: www.clinicaltrials.gov; study number: NCT00411294.

PII: S0272-6386(07)00727-5

doi: 10.1053/j.ajkd.2007.04.010

American Journal of Kidney Diseases
Volume 50, Issue 1 , Pages 59-68 , July 2007

Article Tools

* Image Usage & Resolution